JPH08113521A - 2,4,6-trihydroxychalcone and cosmetic containing the same - Google Patents
2,4,6-trihydroxychalcone and cosmetic containing the sameInfo
- Publication number
- JPH08113521A JPH08113521A JP27589494A JP27589494A JPH08113521A JP H08113521 A JPH08113521 A JP H08113521A JP 27589494 A JP27589494 A JP 27589494A JP 27589494 A JP27589494 A JP 27589494A JP H08113521 A JPH08113521 A JP H08113521A
- Authority
- JP
- Japan
- Prior art keywords
- ultraviolet
- trihydroxychalcone
- absorber
- ultraviolet absorber
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 19
- JEPSZTLDPWGHPQ-UHFFFAOYSA-N 1-phenyl-3-(2,4,6-trihydroxyphenyl)prop-2-en-1-one Chemical compound OC1=CC(O)=CC(O)=C1C=CC(=O)C1=CC=CC=C1 JEPSZTLDPWGHPQ-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims abstract description 21
- 239000002250 absorbent Substances 0.000 claims description 5
- 230000002745 absorbent Effects 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 239000006071 cream Substances 0.000 abstract description 8
- 239000006210 lotion Substances 0.000 abstract description 6
- 239000006096 absorbing agent Substances 0.000 abstract description 4
- 238000002835 absorbance Methods 0.000 abstract description 3
- 238000000622 liquid--liquid extraction Methods 0.000 abstract description 3
- 239000002798 polar solvent Substances 0.000 abstract description 3
- 238000000638 solvent extraction Methods 0.000 abstract description 3
- 238000009835 boiling Methods 0.000 abstract description 2
- 238000004440 column chromatography Methods 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 abstract 4
- 235000000126 Styrax benzoin Nutrition 0.000 abstract 2
- 244000028419 Styrax benzoin Species 0.000 abstract 2
- 235000008411 Sumatra benzointree Nutrition 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 229960002130 benzoin Drugs 0.000 abstract 2
- 235000019382 gum benzoic Nutrition 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 238000009472 formulation Methods 0.000 description 10
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- -1 polyoxyethylene Polymers 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 230000004224 protection Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 5
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 5
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 5
- 229960002216 methylparaben Drugs 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- 229940099259 vaseline Drugs 0.000 description 5
- 206010040914 Skin reaction Diseases 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 230000035483 skin reaction Effects 0.000 description 4
- 231100000430 skin reaction Toxicity 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 229940067596 butylparaben Drugs 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000005417 aminobenzoic acid derivatives Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940071180 lauryl sulfosuccinate Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は2,4,6−トリヒドロ
キシカルコンからなる紫外線吸収剤とそれを含有する化
粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an ultraviolet absorber composed of 2,4,6-trihydroxychalcone and a cosmetic containing the same.
【0002】[0002]
【従来の技術】近年、炎症や皮膚癌誘発の危険性がある
ことから、紫外線Bを中心に、紫外線からの皮膚防護に
ついての消費者の意識が高まっている。更に、紫外線A
についても安全性上好ましくないことが多数の学会で指
摘され、これに対する防護の必要性が強調されている。2. Description of the Related Art In recent years, due to the risk of inflammation and induction of skin cancer, consumers have been conscious of protecting the skin from UV rays, especially UV rays B. Furthermore, ultraviolet rays A
It was pointed out by many academic societies that this is not preferable in terms of safety, and the need for protection against this was emphasized.
【0003】これに対して、今まで紫外線に対する防護
としては、化粧料の分野においては、酸化チタン等の隠
蔽剤によって紫外線を散乱させる化粧料や、ベンゾフェ
ノン誘導体、桂皮酸誘導体、パラアミノ安息香酸誘導体
等の紫外線吸収剤を配合して、紫外線が皮膚に至る以前
に吸収してしまう化粧料等によって行っていた。On the other hand, as protection against ultraviolet rays, in the field of cosmetics, cosmetics in which ultraviolet rays are scattered by a masking agent such as titanium oxide, benzophenone derivatives, cinnamic acid derivatives, para-aminobenzoic acid derivatives, etc. This is done by using a cosmetic or the like that absorbs the ultraviolet rays before they reach the skin by blending the ultraviolet absorber.
【0004】しかしながら、酸化チタンによる散乱によ
る保護では、防護に有効な量の酸化チタンを配合する
と、酸化チタンの外観色の影響を受け異常に白くなった
り、例え他の有色顔料を配合して調色したとしても厚ぼ
ったい感じの仕上がりになってしまい不自然な感じを他
人に与えかねなかった。又、従来の紫外線吸収剤は遅延
型アレルギーの原因物質と疑われる等安全性上の問題も
少なくなく、更に紫外線Aについては吸収がなく、紫外
線Aに対する防護が出来ず充分とは言えなかった。However, in the case of protection due to scattering by titanium oxide, if a titanium oxide in an amount effective for protection is added, the appearance color of the titanium oxide is affected and the color becomes abnormally white. Even if it was colored, the finish would be thick and could give an unnatural feeling to others. Further, conventional ultraviolet absorbers have many safety problems such as suspected causative substances of delayed-type allergy. Further, they do not absorb ultraviolet A and cannot protect against ultraviolet A, which is not sufficient.
【0005】一方、2,4,6−トリヒドロキシカルコ
ンは既知物質ありクロモジの樹皮に存在することがしら
れているが、この物質が紫外線防護に有効であることも
化粧料に配合して紫外線の防護に用いることも全く知ら
れていなかった。On the other hand, 2,4,6-trihydroxychalcone is a known substance, and it is known that it exists in the bark of Chromodis. It is also known that this substance is effective for protection against ultraviolet rays. It was never known to be used for the protection of.
【0006】[0006]
【発明が解決しようとする課題】本発明は上記実状を鑑
みて為されたものであり、従って紫外線A、紫外線Bの
両方について防護し得る紫外線吸収剤を提供することを
課題とする。SUMMARY OF THE INVENTION The present invention has been made in view of the above circumstances, and it is therefore an object of the present invention to provide an ultraviolet absorber capable of protecting both ultraviolet rays A and ultraviolet rays B.
【0007】[0007]
【課題を解決するための手段】この様な状況を踏まえ
て、本発明者らは各種有機化合物について紫外線吸収ス
ペクトルを指標に、紫外線A及びB領域に強度の吸収を
有する物質を捜し求めたところ、2,4,6−トリヒド
ロキシカルコンにその性質を見いだし発明を完成させ
た。以下に本発明について更に詳しく説明する。In view of such circumstances, the present inventors have searched for substances having strong absorption in the ultraviolet A and B regions using various organic compounds with the ultraviolet absorption spectrum as an index. The property was found in 2,4,6-trihydroxychalcone and the invention was completed. The present invention will be described in more detail below.
【0008】(1)本発明の紫外線吸収剤 本発明の紫外線吸収剤は2,4,6−トリヒドロキシカ
ルコンからなる。2,4,6−トリヒドロキシカルコン
は構造式(I)に示される構造を有しており、クスノキ
科の植物であるクロモジ中に高濃度で存在していること
が知られている。この物質は紫外部A及びBに吸収を持
っており、取り分け注目すべきは、従来この領域に吸収
を持つものが極めて少ない紫外線A領域に於いて吸収極
大(343nm)を有しており、その吸光度は1%当た
りの吸光度係数で980と高いことであり、紫外線Bの
みならずAをも吸収し得る紫外線吸収剤として使用でき
る。また、紫外線1万カウントを照射後も90%程度の
残存率を有しており安定性にも優れる。この2,4,6
−トリヒドロキシカルコンをクロモジ樹皮より得る方法
は、クロモジ樹皮に1〜20倍量の極性溶媒を加え、室
温或いは沸点付近の温度で加熱して抽出すれば良い。こ
の時、樹皮はそのまま用いても良いし、乾燥、細切、粉
砕などの前処理をして用いても構わない。抽出時間は室
温であれば数日、加熱下であれば数時間が適当である。
用いる極性溶媒としては、メタノールやエタノール等の
アルコール類、アセトンやメチルエチルケトン等のケト
ン類、ジエチルエーテルやテトラヒドロフラン等のエー
テル類、クロロホルムや塩化メチレン等のハロゲン化炭
化水素類、酢酸エチルや蟻酸メチル等のエステル類、ア
セトニトリル等のニトリル類、水等が好適に例示でき
る。これらは単独で唯一種用いても良いし、数種を混合
して用いても良い。かくして得られた抽出物は溶媒除去
した後、液液抽出、カラムクロマトグラフィー等の通常
の方法で精製すれば、本発明の紫外線吸収剤である2,
4,6−トリヒドロキシカルコンを得ることが出来る。(1) Ultraviolet absorber of the present invention The ultraviolet absorber of the present invention comprises 2,4,6-trihydroxychalcone. 2,4,6-trihydroxychalcone has a structure represented by the structural formula (I), and it is known that it exists in a high concentration in Chromodis which is a plant of the Lauraceae family. This substance has absorption in the ultraviolet regions A and B, and it should be noted that the substance has an absorption maximum (343 nm) in the ultraviolet region A, which has very few substances having absorption in this region. Since the absorbance is as high as 980 in terms of the absorbance coefficient per 1%, it can be used as an ultraviolet absorber capable of absorbing not only B but also B. Further, it has a residual rate of about 90% even after irradiation with 10,000 counts of ultraviolet rays, and is excellent in stability. These 2, 4, 6
The method for obtaining trihydroxychalcone from Chromody bark may be carried out by adding 1 to 20 times the amount of a polar solvent to Chromody bark and heating at room temperature or a temperature near the boiling point for extraction. At this time, the bark may be used as it is, or may be used after being subjected to pretreatment such as drying, chopping and crushing. A suitable extraction time is several days at room temperature, and a few hours if heated.
Examples of polar solvents used include alcohols such as methanol and ethanol, ketones such as acetone and methyl ethyl ketone, ethers such as diethyl ether and tetrahydrofuran, halogenated hydrocarbons such as chloroform and methylene chloride, ethyl acetate and methyl formate, etc. Preferable examples thereof include esters, nitriles such as acetonitrile, water and the like. These may be used alone or as a mixture of several kinds. The thus-obtained extract is, after removing the solvent, purified by a usual method such as liquid-liquid extraction or column chromatography to obtain the ultraviolet absorbent of the present invention,
4,6-trihydroxychalcone can be obtained.
【0009】[0009]
【化2】 Embedded image
【0010】(2)本発明の化粧料 本発明の化粧料は、上記紫外線吸収剤を含有することを
特徴とする。本発明の化粧料において、上記紫外線吸収
剤の好ましい配合量は、0.01〜10重量%である。
これは、0.01重量%未満では紫外線吸収能が小さす
ぎて、紫外線からの防護が不十分であることがあり、1
0重量%を越えても効果が頭打ちになることがあるから
である。更に好ましい配合量は、効果が濃度に対して明
確な0.1〜5重量%である。(2) Cosmetic of the present invention The cosmetic of the present invention is characterized by containing the above-mentioned ultraviolet absorber. In the cosmetic of the present invention, the preferable blending amount of the ultraviolet absorber is 0.01 to 10% by weight.
If it is less than 0.01% by weight, the ultraviolet absorption capacity is too small and the protection from ultraviolet rays may be insufficient.
This is because the effect may reach the ceiling even if it exceeds 0% by weight. A more preferable blending amount is 0.1 to 5% by weight, which has a clear effect on the concentration.
【0011】本発明の化粧料は上記紫外線吸収剤以外に
通常化粧料で用いられている各種の任意成分を含有する
ことが出来る。任意成分としては、ワセリンやスクワラ
ン等の炭化水素類、ホホバ油や合成ゲイロウなどのエス
テル類、オリーブ油や水添ヤシ油等のトリグリセライド
類、セチルアルコールやオレイルアルコール等のアルコ
ール類、ステアリン酸やオレイン酸等の脂肪酸類、ステ
アリン酸モノグリセライドやポリオキシエチレン硬化ひ
まし油等のノニオン界面活性剤類、ラウリル硫酸ナトリ
ウムやスルホコハク酸エステル等のアニオン界面活性剤
類、アルキルアミン塩酸塩等のカチオン界面活性剤類、
グリセリンや1,3−ブタンジオール等の多価アルコー
ル類、アルキルベタイン等の両性界面活性剤類、パラベ
ン等の防腐剤、BHT等の抗酸化剤、パラアミノ安息香
酸エステル誘導体類等の紫外線吸収剤、グァーガム等の
増粘剤類、アルカリや燐酸塩等のpH調節剤、ビタミン
等の各種薬効成分等が例示できる。更に、ベンゾフェノ
ン誘導体、アミノ安息香酸誘導体、桂皮酸誘導等の従来
の紫外線吸収剤や酸化チタンや酸化亜鉛等の散乱剤を配
合することもできる。The cosmetic of the present invention may contain various optional components usually used in cosmetics in addition to the above-mentioned ultraviolet absorber. As an optional component, hydrocarbons such as petrolatum and squalane, esters such as jojoba oil and synthetic geiro, triglycerides such as olive oil and hydrogenated coconut oil, alcohols such as cetyl alcohol and oleyl alcohol, stearic acid and oleic acid. Fatty acids such as, nonionic surfactants such as stearic acid monoglyceride and polyoxyethylene hydrogenated castor oil, anionic surfactants such as sodium lauryl sulfate and sulfosuccinate, cationic surfactants such as alkylamine hydrochloride,
Polyhydric alcohols such as glycerin and 1,3-butanediol, amphoteric surfactants such as alkylbetaine, preservatives such as parabens, antioxidants such as BHT, and ultraviolet absorbers such as paraaminobenzoic acid ester derivatives, Examples thereof include thickeners such as guar gum, pH adjusting agents such as alkali and phosphate, and various medicinal ingredients such as vitamins. Furthermore, a conventional ultraviolet absorber such as a benzophenone derivative, an aminobenzoic acid derivative, a cinnamic acid derivative, or a scattering agent such as titanium oxide or zinc oxide may be added.
【0012】本発明の化粧料の剤形は、特に限定はされ
ないが、クリーム、乳液、化粧水の様に皮膚に塗布する
基礎化粧料が好ましい。又、アイカラー、チークカラ
ー、ファンデーション、アンダーメークアップ等のメー
クアップ化粧料に配合しても良い。The dosage form of the cosmetic of the present invention is not particularly limited, but basic cosmetics such as creams, emulsions and lotions applied to the skin are preferable. Further, it may be blended in makeup cosmetics such as eye color, cheek color, foundation, and under makeup.
【0013】[0013]
【実施例】以下に実施例を挙げて更に詳しく本発明につ
いて説明するが、本発明がこれら実施例に何等限定を受
けないことは言うまでもない。The present invention will be described in more detail with reference to the following examples, but it goes without saying that the present invention is not limited to these examples.
【0014】実施例1 製造例 クロモジの樹皮1.7Kgにメタノール8l加え、3時
間加熱還流し濾過により不溶物を除去した後減圧濃縮
し、これにクロロホルムと水を1lづつ加え液液抽出
し、クロロホルム層を取り出し溶媒を除去し、シリカゲ
ルカラムクロマトグラフィーにより精製し(溶出溶媒;
クロロホルム:メタノール=100:0→50:50)
780mgの2,4,6−トリヒドロキシカルコン(紫
外線吸収剤1)を得た。Example 1 Production Example 8 kg of bark of Chromody was added to 8 l of methanol, and the mixture was heated under reflux for 3 hours to remove insoluble matter by filtration, and then concentrated under reduced pressure. Chloroform and water were added to each in an amount of 1 l to perform liquid-liquid extraction, The chloroform layer is taken out, the solvent is removed, and the product is purified by silica gel column chromatography (elution solvent;
Chloroform: methanol = 100: 0 → 50: 50)
780 mg of 2,4,6-trihydroxychalcone (UV absorber 1) was obtained.
【0015】実施例2 経皮毒性 ハートレー系雄性モルモット(300−350g)6匹
を用いて実施例1の紫外線吸収剤1の安全性を調べた。
即ち、モルモットの背部を剃毛し、2×2cmの部位を
3個作った。1個は無処置コントロール部位としそれ以
後何も操作はせず、もう1個はベヒクルコントロールと
し、ワセリン0.05gを塗布した。残る1個は検体投
与部位とし、紫外線吸収剤1を10重量%の割合でワセ
リン中に混練りしたものを塗布した。24時間後及び4
8時間後同じ検体を投与し、72時間目に皮膚反応を下
記のドレーズの基準を用いて判定した。結果は何れの部
位も皮膚反応を認めず(−)の判定であった。これよ
り、本発明の紫外線吸収剤は安全性に優れることが判
る。Example 2 Transdermal Toxicity The safety of the ultraviolet absorbent 1 of Example 1 was examined using 6 Hartley male guinea pigs (300-350 g).
That is, the back of the guinea pig was shaved to make three 2 × 2 cm parts. One was a non-treated control site and no operation was performed thereafter, and the other was a vehicle control, and 0.05 g of vaseline was applied. The remaining one was used as a sample administration site, and the ultraviolet absorber 1 kneaded in vaseline at a ratio of 10% by weight was applied. 24 hours later and 4
The same sample was administered 8 hours later, and the skin reaction was evaluated 72 hours later using the following Draize standard. As a result, no skin reaction was observed in any of the parts, and the judgment was (-). From this, it is understood that the ultraviolet absorber of the present invention is excellent in safety.
【0016】〔ドレーズの基準〕 −:無反応 ±:擬陽性反応 +:陽性反応 ++:浮腫を伴う反応[Criteria for Draize] −: No reaction ±: False positive reaction +: Positive reaction ++: Reaction with edema
【0017】実施例3 配合例 下記の処方に基づいて化粧水を作成した。即ち、処方成
分を80℃で加熱攪拌し可溶化した後、冷却し化粧水を
得た。以後、数値は全て重量部を表す。 エタノール 15 1,3−ブタンジオール 5 グリセリン 5 メチルパラベン 0.2 香料 0.1 紫外線吸収剤1 0.05 水 79.65Example 3 Formulation Example A lotion was prepared based on the following formulation. That is, the prescription ingredients were heated and stirred at 80 ° C. to solubilize them, and then cooled to obtain a lotion. Hereinafter, all numerical values represent parts by weight. Ethanol 15 1,3-butanediol 5 Glycerin 5 Methylparaben 0.2 Perfume 0.1 UV absorber 1 0.05 Water 79.65
【0018】実施例4 配合例 下記の処方に基づいて化粧水を作成した。即ち、処方成
分を80℃で加熱攪拌し可溶化した後、冷却し化粧水を
得た。 エタノール 15 1,3−ブタンジオール 5 グリセリン 5 メチルパラベン 0.2 香料 0.1 紫外線吸収剤1 0.1 パラアミノ安息香酸オクチル 0.1 水 79.5Example 4 Formulation Example A lotion was prepared based on the following formulation. That is, the prescription ingredients were heated and stirred at 80 ° C. to solubilize them and then cooled to obtain a lotion. Ethanol 15 1,3-Butanediol 5 Glycerin 5 Methylparaben 0.2 Perfume 0.1 UV absorber 1 0.1 Octyl paraaminobenzoate 0.1 Water 79.5
【0019】実施例5 配合例 下記の処方にしたがってクリームを作成した。即ち、
A、Bをそれぞれ秤込み、80℃で加熱攪拌し、AにB
を攪拌しながら徐々に加え、乳化した。これを攪拌しな
がら冷却しクリームを得た。 (A)セタノール 1 合成ゲイロウ 2.5 ミツロウ 2.5 ステアリン酸 1 ワセリン 3 スクワラン 14 オリーブ油 6 トコフェロール 0.1 ブチルパラベン 0.1 グリセリルモノステアレート 2.5 ポリオキシエチレン(25)ステアレート 2.5 紫外線吸収剤1 1 (B)苛性カリ 0.02 水 55.43 1,3−ブタンジオール 8 メチルパラベン 0.25Example 5 Formulation Example A cream was prepared according to the following formulation. That is,
Weigh A and B separately, heat and stir at 80 ° C, and add A to B
Was gradually added with stirring to emulsify. This was cooled with stirring to obtain a cream. (A) Cetanol 1 Synthetic Geiro 2.5 Beeswax 2.5 Stearic acid 1 Vaseline 3 Squalane 14 Olive oil 6 Tocopherol 0.1 Butylparaben 0.1 Glyceryl monostearate 2.5 Polyoxyethylene (25) Stearate 2.5 UV absorber 1 1 (B) caustic potash 0.02 water 55.43 1,3-butanediol 8 methylparaben 0.25
【0020】実施例6 配合例 下記の処方にしたがってクリームを作成した。即ち、
A、Bをそれぞれ秤込み、80℃で加熱攪拌し、AにB
を攪拌しながら徐々に加え、乳化した。これを攪拌しな
がら冷却しクリームを得た。 (A)セタノール 1 合成ゲイロウ 2.5 ミツロウ 2.5 ステアリン酸 1 ワセリン 3 スクワラン 14 オリーブ油 6 トコフェロール 0.1 ブチルパラベン 0.1 グリセリルモノステアレート 2.5 ポリオキシエチレン(25)ステアレート 2.5 紫外線吸収剤1 0.1 (B)苛性カリ 0.02 水 56.33 1,3−ブタンジオール 8 メチルパラベン 0.25Example 6 Formulation Example A cream was prepared according to the following formulation. That is,
Weigh A and B separately, heat and stir at 80 ° C, and add A to B
Was gradually added with stirring to emulsify. This was cooled with stirring to obtain a cream. (A) Cetanol 1 Synthetic Geiro 2.5 Beeswax 2.5 Stearic acid 1 Vaseline 3 Squalane 14 Olive oil 6 Tocopherol 0.1 Butylparaben 0.1 Glyceryl monostearate 2.5 Polyoxyethylene (25) Stearate 2.5 UV absorber 1 0.1 (B) caustic potash 0.02 water 56.33 1,3-butanediol 8 methylparaben 0.25
【0021】実施例7 配合例 下記の処方に従ってファンデーションを作成した。即
ち、Aを混練りした後Bを加え更に混練りし、80℃に
加熱した後Cを分散させ、80℃に加熱溶解したDを徐
々に加え乳化し、攪拌冷却しファンデーションを得た。 (A)1,3−ブタンジオール 5 マルビトール 10 メチルパラベン 0.3 ジグリセリントリイソステアレート 4 (B)流動パラフィン 5 ブチルパラベン 0.1 紫外線吸収剤1 0.6 (C)酸化チタン 9 黄色酸化鉄 1.7 ベンガラ 1.2 タルク 8.1 (D)水 55Example 7 Formulation Example A foundation was prepared according to the following formulation. That is, after kneading A, B was added and further kneaded, and after heating to 80 ° C., C was dispersed, D which was heated and dissolved at 80 ° C. was gradually added to emulsify, and the mixture was stirred and cooled to obtain a foundation. (A) 1,3-butanediol 5 malbitol 10 methylparaben 0.3 diglycerin triisostearate 4 (B) liquid paraffin 5 butylparaben 0.1 ultraviolet absorber 1 0.6 (C) titanium oxide 9 yellow iron oxide 1.7 Red iron oxide 1.2 Talc 8.1 (D) Water 55
【0022】実施例8 光防護作用 被験者5名の上腕部を用いて実施例6のクリームのBL
Bランプ及びSEランプを光源とした光に対する光防護
作用を確かめた。即ち、被験者5名のBLBランプとS
Eランプを4本づつ装着した光源に対するに於ける最少
紅斑濃度(MED)を予め求めておき、実施例6のクリ
ームを0.01g、上腕部に設けた1cm×1cmの部
位に塗布し、MEDの2倍の線量の光を照射した。照射
後24時間に皮膚反応を下記に示す本邦パッチテスト基
準を用いて判定した。結果は何れのパネラーも無反応
(−)であった。更に、照射後1週間、2週間、3週
間、4週間に皮膚のターニングについての観察を行った
が、照射部位と非照射部位の間の差異は認められなかっ
た。これらの観察より、本発明の紫外線吸収剤を含有す
る化粧料が、光、取り分け紫外線A及びBからの保護に
優れることが判る。Example 8 Photoprotective action BL of cream of Example 6 using the upper arm of 5 subjects
The photoprotective action against light using the B lamp and the SE lamp as a light source was confirmed. That is, the BLB lamp and S of the five subjects
The minimum erythema concentration (MED) for a light source equipped with four E lamps was obtained in advance, and 0.01 g of the cream of Example 6 was applied to a 1 cm × 1 cm site provided on the upper arm, and MED was applied. Of double dose of light. Twenty-four hours after irradiation, the skin reaction was evaluated using the Japanese patch test criteria shown below. As a result, none of the panelists reacted (-). Furthermore, the skin turning was observed 1 week, 2 weeks, 3 weeks and 4 weeks after irradiation, but no difference was observed between the irradiated and non-irradiated sites. From these observations, it can be seen that the cosmetic containing the ultraviolet absorbent of the present invention is excellent in protection from light and especially ultraviolet rays A and B.
【0023】〔本邦パッチテスト基準〕 −:無反応 ±:擬陽性反応 +:陽性反応 ++:浮腫を伴う反応[Japanese Patch Test Criteria] −: No reaction ±: False positive reaction +: Positive reaction ++: Reaction with edema
【0024】実施例9 ヒトパッチテスト 更に安全性の高さを確認するために、本発明の紫外線吸
収剤について、男子11名を用いて、24時間クローズ
ドパッチテストを行った。即ち、上腕部にワセリン中に
5重量%の濃度で本発明の実施例1の紫外線吸収剤を練
り混んだサンプルを0.025gパッチ用絆創膏のリン
ト布に塗布し、24時間クローズドパッチした。パッチ
用絆創膏の除去後1時間及び24時間に上記の本邦パッ
チテスト基準を用いて皮膚反応を観察した。結果は何れ
のパネラーも全ての観察時に於いても無反応(−)であ
り、本発明の紫外線吸収剤が人に於いても極めて安全で
あることが確認された。Example 9 Human Patch Test Further, in order to confirm the high level of safety, a closed patch test for 24 hours was conducted using 11 males with the ultraviolet absorbent of the present invention. That is, a sample prepared by kneading the ultraviolet absorber of Example 1 of the present invention in vaseline at a concentration of 5% by weight on the upper arm was applied to a lint cloth of a patch plaster for 0.025 g, and closed patch was applied for 24 hours. The skin reaction was observed 1 and 24 hours after removal of the patch plaster using the above Japanese patch test standard. As a result, all panelists showed no reaction (-) at all observations, and it was confirmed that the ultraviolet absorber of the present invention is extremely safe for humans.
【0025】[0025]
【発明の効果】本発明の2,4,6−トリヒドロキシカ
ルコンからなる紫外線吸収剤は安全性が高い上、紫外線
A及びB領域に強い吸収を有するので化粧料の原料とし
て大変有用である。EFFECTS OF THE INVENTION The ultraviolet absorber comprising 2,4,6-trihydroxychalcone of the present invention is highly safe and has a strong absorption in the ultraviolet A and B regions, and therefore is very useful as a raw material for cosmetics.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 松原 顕吉 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 原 烈 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 北田 好男 神奈川県横浜市戸塚区柏尾町560 ポーラ 化成工業株式会社戸塚研究所内 (72)発明者 中島 琢自 神奈川県横浜市戸塚区柏尾町560 ポーラ 化成工業株式会社戸塚研究所内 (72)発明者 大郷 保治 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 大畑 智 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 宮田 善之 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Akiyoshi Matsubara 27 Takashimadai, Kanagawa-ku, Kanagawa-ku, Kanagawa Prefecture 1 Yokohama Research Laboratory, Pola Chemical Industry Co., Ltd. (72) Inventor Takeru 27 Takashimadai, Kanagawa-ku, Yokohama-shi, Kanagawa 1 Pola Chemical Industry Co., Ltd. Yokohama Research Laboratory (72) Inventor Yoshio Kitada 560 Kashio-cho, Totsuka-ku, Yokohama-shi, Kanagawa Prefecture Pola Chemical Industry Co., Ltd. Totsuka Research Laboratory (72) Inventor Taku Nakajima Kashio-cho, Totsuka-ku, Yokohama-shi, Kanagawa Prefecture 560 Pola Kasei Kogyo Co., Ltd. in the Totsuka Research Institute (72) Inventor Houji Hogo 1 Takashimadai 27 Takashimadai, Kanagawa-ku, Yokohama, Kanagawa Prefecture Pola Kasei Kogyo Co., Ltd. in Yokohama Research Laboratory (72) Satoshi Ohata, Takashimadai, Kanagawa-ku, Kanagawa Address 27, Yokohama Research Laboratory, Pola Chemical Industry Co., Ltd. (72) Inventor Yoshiyuki Miyata River Prefecture, Kanagawa-ku, Yokohama-shi Takashimadai 27 address 1 Pola Chemical Industry Co., Ltd. Yokohama within the Institute
Claims (3)
リヒドロキシカルコンからなる紫外線吸収剤。 【化1】 1. An ultraviolet absorber comprising 2,4,6-trihydroxychalcone represented by structural formula (I). Embedded image
化粧料。2. A cosmetic containing the ultraviolet absorbent according to claim 1.
0.01〜10重量%である、請求項2記載の化粧料。3. The cosmetic according to claim 2, wherein the content of the ultraviolet absorber according to claim 1 is 0.01 to 10% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27589494A JP3412931B2 (en) | 1994-10-14 | 1994-10-14 | 2,4,6-trihydroxychalcone and cosmetics containing it |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27589494A JP3412931B2 (en) | 1994-10-14 | 1994-10-14 | 2,4,6-trihydroxychalcone and cosmetics containing it |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08113521A true JPH08113521A (en) | 1996-05-07 |
JP3412931B2 JP3412931B2 (en) | 2003-06-03 |
Family
ID=17561927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27589494A Expired - Fee Related JP3412931B2 (en) | 1994-10-14 | 1994-10-14 | 2,4,6-trihydroxychalcone and cosmetics containing it |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3412931B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6051602A (en) * | 1998-03-16 | 2000-04-18 | The Procter & Gamble Company | Methods for regulating skin appearance |
JP2000328039A (en) * | 1999-05-19 | 2000-11-28 | Hayashibara Biochem Lab Inc | Light absorber |
US6183761B1 (en) | 1998-03-16 | 2001-02-06 | The Procter & Gamble Company | Compositions for regulating skin appearance |
JP2013189393A (en) * | 2012-03-13 | 2013-09-26 | Kyoto Univ | Ultraviolet absorber |
-
1994
- 1994-10-14 JP JP27589494A patent/JP3412931B2/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6051602A (en) * | 1998-03-16 | 2000-04-18 | The Procter & Gamble Company | Methods for regulating skin appearance |
US6183761B1 (en) | 1998-03-16 | 2001-02-06 | The Procter & Gamble Company | Compositions for regulating skin appearance |
US6235773B1 (en) | 1998-03-16 | 2001-05-22 | The Procter & Gamble Company | Compositions for regulating skin appearance |
JP2000328039A (en) * | 1999-05-19 | 2000-11-28 | Hayashibara Biochem Lab Inc | Light absorber |
JP2013189393A (en) * | 2012-03-13 | 2013-09-26 | Kyoto Univ | Ultraviolet absorber |
US9254249B2 (en) | 2012-03-13 | 2016-02-09 | Kao Corporation | Ultraviolet absorber |
Also Published As
Publication number | Publication date |
---|---|
JP3412931B2 (en) | 2003-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69221686T2 (en) | THERAPEUTIC AND COSMETIC COMPOSITIONS FOR SKIN TREATMENT | |
JPH08119825A (en) | Hydroxytyrosol, application for skin external medicine or bathing agent | |
JP3415200B2 (en) | External preparation for skin | |
JPH064529B2 (en) | External skin preparation | |
JP3412931B2 (en) | 2,4,6-trihydroxychalcone and cosmetics containing it | |
JP2986966B2 (en) | Melanin production inhibitor | |
JPH11349435A (en) | Skin agent used for external use and effective for preventing and improving pigmentary symptom caused by ultraviolet light | |
JPH11171723A (en) | Antioxidant | |
JPH08133955A (en) | Skin preparation for external use | |
JP3432033B2 (en) | Photoaging agent and skin cosmetic containing the same | |
JP3207996B2 (en) | Sunscreen cosmetics | |
JPH10158143A (en) | Photo-aging prevention and improving agent and skin cosmetic | |
JPH10158142A (en) | Photo-aging prevention or improvement agent and skin preparation for external use | |
JPS61215311A (en) | External agent for skin | |
DE2338833A1 (en) | LIGHT PROTECTIVE PREPARATION FOR PHARMACEUTICAL AND / OR COSMETIC PURPOSES | |
JPH06321760A (en) | Skin beautifying agent | |
JPH08157346A (en) | Ultraviolet absorbing skin cosmetic | |
JPH09255551A (en) | Skin preparation for external use | |
JPH08301745A (en) | Skin cosmetic | |
JPS62234006A (en) | External drug for skin | |
JP3150845B2 (en) | UV absorbers and UV protection cosmetics containing the same | |
JPS62181213A (en) | Long-wavelength ultraviolet light absorber | |
JP2005306768A (en) | Skin care preparation for external use for summer | |
JP4404352B2 (en) | Skin preparation for summer | |
JPH0692833A (en) | Skin external agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |